EVOK Logo

Evoke Pharma, Inc. (EVOK) 

NASDAQ
Market Cap
$4.64M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
577 of 809
Rank in Industry
32 of 53

Largest Insider Buys in Sector

EVOK Stock Price History Chart

EVOK Stock Performance

About Evoke Pharma, Inc.

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Insider Activity of Evoke Pharma, Inc.

Over the last 12 months, insiders at Evoke Pharma, Inc. have bought $0 and sold $0 worth of Evoke Pharma, Inc. stock.

On average, over the past 5 years, insiders at Evoke Pharma, Inc. have bought $0 and sold $343,844 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 500,000 shares for transaction amount of $1.18M was made by LVP GP III, LLC (10 percent owner) on 2018‑08‑20.

List of Insider Buy and Sell Transactions, Evoke Pharma, Inc.

2020-12-14SaleGonyer David APresident and CEO
23,954
0.0936%
$2.94$70,425-54.58%
2020-12-11SaleGonyer David APresident and CEO
48,046
0.1885%
$2.90$139,333-53.45%
2020-12-11SaleD'Onofrio Matthew JExec VP, Chief Bus. Officer
40,357
0.1589%
$2.91$117,439-53.45%
2020-12-10SaleD'Onofrio Matthew JExec VP, Chief Bus. Officer
5,643
0.0226%
$2.95$16,647-53.29%
2018-08-20PurchaseLVP GP III, LLC10 percent owner
500,000
2.8821%
$2.35$1.18M-2.52%
2017-02-22PurchaseWIDDER KENNETH Jdirector
450,000
3.0145%
$2.90$1.3M-17.03%
2016-05-26SaleDOMAIN PARTERS VII L P10 percent owner
688,240
8.3615%
$4.70$3.23M-52.43%
2016-05-26SaleDP VII ASSOCIATES LP10 percent owner
11,760
0.1429%
$4.70$55,272-52.43%
2016-04-27SaleDOMAIN PARTERS VII L P10 percent owner
7,206
0.1042%
$5.02$36,174-46.99%
2016-04-27SaleDP VII ASSOCIATES LP10 percent owner
122
0.0018%
$5.02$612-46.99%
2016-04-25SaleDOMAIN PARTERS VII L P10 percent owner
2,984
0.0409%
$5.20$15,517-51.43%
2016-04-25SaleDP VII ASSOCIATES LP10 percent owner
42
0.0006%
$5.20$218-51.43%
2016-04-20SaleDOMAIN PARTERS VII L P10 percent owner
8,848
0.1254%
$5.29$46,806-50.19%
2016-04-20SaleDP VII ASSOCIATES LP10 percent owner
152
0.0022%
$5.29$804-50.19%
2016-04-19SaleDOMAIN PARTERS VII L P10 percent owner
74,108
1.0666%
$5.36$397,219-50.00%
2016-04-19SaleDP VII ASSOCIATES LP10 percent owner
1,264
0.0182%
$5.36$6,775-50.00%
2016-04-11SaleDOMAIN PARTERS VII L P10 percent owner
8,696
0.1207%
$5.22$45,393-50.10%
2016-04-11SaleDP VII ASSOCIATES LP10 percent owner
150
0.0021%
$5.22$783-50.10%
2016-04-08SaleDOMAIN PARTERS VII L P10 percent owner
29,108
0.4165%
$5.35$155,728-50.19%
2016-04-08SaleDP VII ASSOCIATES LP10 percent owner
502
0.0072%
$5.35$2,686-50.19%

Insider Historical Profitability

<0.0001%
LVP GP III, LLC10 percent owner
1937983
57.9702%
$0.5410
WIDDER KENNETH Jdirector
1472867
44.0573%
$0.5410<0.0001%
DOMAIN PARTERS VII L P10 percent owner
606283
18.1355%
$0.54013
Gonyer David APresident and CEO
339782
10.1638%
$0.5402
D'Onofrio Matthew JExec VP, Chief Bus. Officer
283997
8.4951%
$0.5402
DP VII ASSOCIATES LP10 percent owner
10328
0.3089%
$0.54013
Brady Todd Cdirector
4000
0.1197%
$0.5410

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
No records found…